Washington State Researchers Develop 3D-Printed Heart Model That Contracts and Beats Like a Real Organ

Scientists at the University of Washington have created a groundbreaking 3D-printed heart model that not only replicates the structure of a human heart but similarly contracts and beats in a lifelike manner. This advancement represents a significant step forward in biomedical engineering, offering new possibilities for cardiac research, surgical planning, and medical education.

The model, developed using a specialized bioink composed of human-derived cells and hydrogel materials, mimics the mechanical properties of cardiac tissue. When stimulated electrically, the printed structure exhibits coordinated contractions similar to those of a real heartbeat. Researchers say this functionality allows the model to serve as a dynamic platform for studying heart disease, testing drug responses, and evaluating potential therapies without relying on animal models or human trials.

“This isn’t just a static replica—it’s a functional tissue construct that responds to stimulation in ways that closely resemble native heart muscle,” said Dr. Kelly Stevens, associate professor of bioengineering at the University of Washington and lead author of the study. “We’re able to observe how the tissue contracts, relaxes, and adapts over time, which gives us invaluable insights into cardiac function.”

The research, published in the journal Biofabrication, details how the team used a technique called stereolithography to print layered structures with precise microarchitectures. By embedding cardiomyocytes—heart muscle cells derived from induced pluripotent stem cells (iPSCs)—into a supportive scaffold, the scientists enabled the cells to align, communicate, and beat in unison.

One of the key innovations lies in the bioink formulation, which supports cell viability and function over extended periods. Unlike earlier 3D-printed tissues that often deteriorated within days, this model maintained contractile function for several weeks, allowing for longitudinal studies.

“Longevity and functionality are critical if we want to use these models for drug screening or disease modeling,” explained Dr. Stevens. “Our goal is to create systems that not only look like organs but behave like them—so we can predict how they’ll respond in real physiological conditions.”

The implications of this technology extend beyond basic research. Surgeons could use patient-specific models to practice complex procedures before entering the operating room. Pharmaceutical companies might employ these constructs to assess cardiotoxicity early in drug development, potentially reducing late-stage failures. The models could help researchers study inherited heart conditions by using iPSCs derived from patients with specific genetic mutations.

While the current model focuses on ventricular tissue, the team is working toward integrating multiple chambers and incorporating vascular networks to simulate blood flow. Future iterations may include pacemaker-like electrical stimulation systems to further mimic the heart’s natural rhythm.

Experts in the field have praised the achievement as a meaningful advance in regenerative medicine. “Creating a 3D-printed heart construct that actually beats is a major milestone,” said Dr. Jennifer Elisseeff, professor of biomedical engineering at Johns Hopkins University, who was not involved in the study. “It brings us closer to the vision of using bioprinted tissues for both research and eventual clinical applications.”

As 3D bioprinting continues to evolve, innovations like this underscore the potential to transform how we study and treat heart disease—the leading cause of death worldwide. With further refinement, functional heart models could one day reduce reliance on animal testing, accelerate personalized medicine, and improve outcomes for patients with cardiovascular conditions.

Key Takeaways

• University of Washington researchers developed a 3D-printed heart model that contracts and beats like real cardiac tissue.
• The model uses human stem cell-derived cardiomyocytes in a specialized bioink to achieve lifelike functionality.
• It maintains contractile function for weeks, enabling long-term studies of heart disease and drug responses.
• Applications include surgical planning, pharmaceutical testing, and modeling inherited heart conditions.
• Future operate aims to incorporate multiple chambers and vascular networks for greater physiological realism.

Frequently Asked Questions

Is the 3D-printed heart capable of pumping blood?

Not yet. The current model demonstrates coordinated contractions but does not include a full circulatory system or valves to generate directional blood flow. Researchers are working toward integrating vascular channels to simulate perfusion in future versions.

How is this different from previous 3D-printed heart models?

Earlier models were primarily anatomical replicas made from non-living materials like plastics or silicones. This version incorporates living human cells that actively beat and respond to stimuli, making it a functional tissue construct rather than a passive scaffold.

Can this technology be used for heart transplants?

Not at this stage. While the research advances the field of cardiac tissue engineering, creating a full-size, transplantable heart with all necessary structures and functions remains a long-term goal. Current efforts focus on research and preclinical applications.

Where can I read the full study?

The research was published in Biofabrication and is available through the journal’s website. Access may require a subscription or institutional login.